BGM (BGM Group) NonCurrent Deferred Liabilities: $0.24 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGM BGM Group Ltd BGM
37 GF Score
Price $0.29
GF Value $0.26
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is BGM Group NonCurrent Deferred Liabilities?

BGM Group BGM -0.10% 37 NonCurrent Deferred Liabilities is $0.24 Mil as of Sep. 2025. GuruFocus rates BGM with a GF Score™ of 37/100 and a GF Value™ of $0.26 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

BGM Group's non-current deferred liabilities for the quarter that ended in Sep. 2025 was $0.24 Mil.

BGM Group NonCurrent Deferred Liabilities Related Terms

BGM Group NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for BGM Group's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGM Group NonCurrent Deferred Liabilities Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only 0.40 0.31 0.22 0.13 0.24

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.18 0.13 0.24 0.24
BGM
37GF Score
BGM Group Ltd BGM
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $0.24 Mil mean?
BGM Group (BGM) has a NonCurrent Deferred Liabilities of $0.24 Mil as of Sep. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on BGM Group and its competitors.
Is BGM Group's NonCurrent Deferred Liabilities too high?
BGM Group's current NonCurrent Deferred Liabilities is $0.24 Mil. Overall, BGM Group has a GF Score™ of 37/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BGM Group's NonCurrent Deferred Liabilities compare to INCR and SCYX?
BGM Group's NonCurrent Deferred Liabilities of $0.24 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Drug Manufacturers company?
A good NonCurrent Deferred Liabilities depends on the Drug Manufacturers industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on BGM Group and its competitors. BGM Group's current NonCurrent Deferred Liabilities is $0.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.26, compared to a current price of $0.29 — trading 13.3% above its estimated fair value. The current NonCurrent Deferred Liabilities is $0.24 Mil. BGM Group's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For BGM Group (BGM), the current NonCurrent Deferred Liabilities is $0.24 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BGM Group (BGM) Overvalued in 2026?

Based on GuruFocus' analysis, BGM Group stock appears to be overvalued. The current stock price of $0.29 is trading 13.3% above its estimated GF Value™ of $0.26. GuruFocus considers BGM Group to be Modestly Overvalued.

Key valuation signals for BGM:

  • NonCurrent Deferred Liabilities: $0.24 Mil
  • GF Value™: $0.26 vs. price of $0.29 (13.3% above fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BGM Group Business Description

Address No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
37GF Score

Get the complete analysis for BGM

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price
$0.26
GF Value